From: Neonatal near-misses in Ghana: a prospective, observational, multi-center study
Variable Name | Model 1 (Major Near-Miss Categories) Pseudo R2 = 0.0982 | Model 2 (Aspects of Severe Complications) Pseudo R2 = 0.0746 | Model 3 (Aspects of Interventions) Pseudo R2 = 0.0982 | Model 4 (Aspects of Organ Dysfunction) Pseudo R2 = 0.1517 | Model 5 (Aspects of Investigations) Psuedo R2 = 0.0133 | Model 6 (Model with key predictors from previous models) Pseudo R2 = 0.2176 | Model 7 (Final Model) Pseudo R2 = 0.2092 | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OR | P value | 95% CI | OR | P value | 95% CI | OR | P value | 95% CI | OR | P value | 95% CI | OR | P value | 95% CI | OR | P value | 95% CI | OR | P value | 95% CI | |
Severe Complications | 2.1 | 0.041* | 1.0–4.1 | ||||||||||||||||||
Apgar Score < 7 at 5 min | 1.3 | 0.396 | 0.7–2.3 | ||||||||||||||||||
Gestational Age < 33 wks | 6.4 | < 0.001* | 2.2–18.2 | 3.1 | 0.001* | 1.6–6.0 | 3.0 | 0.001* | 1.6–5.9 | ||||||||||||
Birthweight < 1800 g | 0.5 | 0.194 | 0.2–1.4 | ||||||||||||||||||
Suspected subgaleal bleed | 1.3 | 0.576 | 0.5–3.5 | ||||||||||||||||||
Major congenital abnormality | 2.5 | 0.078 | 0.9–6.9 | ||||||||||||||||||
Axillary temperature < 35 or > 39 | 1.9 | 0.023 | 1.1–3.6 | 1.7 | 0.09 | 0.9–3.3 | |||||||||||||||
Severe jaundice that required blood exchange | 2.2 | 0.265 | 0.6–8.4 | ||||||||||||||||||
Surgery in the first week | 1.0 | 1.0 | 0.9–10.7 | ||||||||||||||||||
Interventions | 1.3 | 0.555 | 0.5–3.1 | ||||||||||||||||||
Resuscitation at delivery | 0.9 | 0.737 | 0.4–1.8 | ||||||||||||||||||
Resuscitation in NICU | 2.0 | 0.069 | 0.9–4.1 | ||||||||||||||||||
Chest compressions | 9.6 | 0.007* | 1.8–50.3 | 8.3 | 0.013* | 1.6–44.4 | 7.2 | 0.019 | 1.4–37.5 | ||||||||||||
IV fluid bolus | 1.3 | 0.426 | 0.7–2.6 | ||||||||||||||||||
Any intubation | 0.7 | 0.748 | 0.1–6.4 | ||||||||||||||||||
Double phototherapy | 1.1 | 0.932 | 0.3–3.2 | ||||||||||||||||||
Double volume exchange blood transfusion | 1.1 | 0.943 | 0.2–4.5 | ||||||||||||||||||
Oxygen therapy | 2.0 | 0.018* | 1.1–3.7 | 0.8 | 0.468 | 0.4–1.6 | |||||||||||||||
Caffeine citrate aminophylline | 0.9 | 0.856 | 0.4–2.2 | ||||||||||||||||||
Thermal protection | 1.4 | 0.379 | 0.7–3.0 | ||||||||||||||||||
Organ System Dysfunction | 3.8 | < 0.001* | 1.9–7.2 | ||||||||||||||||||
Cardiovascular | 2.1 | 0.174 | 0.7–6.4 | ||||||||||||||||||
Neurologic | 2.9 | < 0.001* | 1.6–5.2 | 2.2 | 0.010* | 1.2–4.3 | 2.3 | 0.008* | 1.2–4.2 | ||||||||||||
Respiratory | 4.5 | < 0.001* | 2.4–8.3 | 5.0 | < 0.001* | 2.4–10.1 | 4.6 | < 0.001* | 2.4–8.8 | ||||||||||||
Renal | 1 | (omitted) | – | 3.0 | 0.152 | 0.6–13.8 | |||||||||||||||
Gastroenterologic | 0.4 | 0.435 | 0.04–4.2 | ||||||||||||||||||
Investigations | 1.6 | 0.327 | 0.6–4.2 | ||||||||||||||||||
Hematocrit < 30% in first week | 0.7 | 0.774 | 0.1–5.8 | ||||||||||||||||||
Hemoglobin <10 gd/dl | 4.3 | 0.044* | 1.0–18 .4 | 6.9 | 0.003* | 1.9–24.4 | 6.4 | 0.004* | 1.8–22.8 | ||||||||||||
Blood culture done | 0.9 | 0.649 | 0.5–1.6 | ||||||||||||||||||
Blood culture positive | 3.3 | 0.194 | 0.5–20.4 |